Results 41 to 50 of about 19,061 (206)

The role of pharmacoeconomics in current Indian healthcare system

Journal of Research in Pharmacy Practice, 2013
Phamacoeconomics can aid the policy makers and the healthcare providers in decision making in evaluating the affordability of and access to rational drug use.
Akram Ahmad, Isha Patel, Sundararajan Parimilakrishnan, Guru Prasad Mohanta, HaeChung Chung, Jongwha Chang   +5 more
doaj   +1 more source

Once‐weekly insulin icodec versus once‐daily insulin degludec for type 2 diabetes in China: A cost‐utility and budget impact analysis

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Insulin icodec, the first once‐weekly basal insulin analogue, was approved in China in 2024. Although it has demonstrated robust clinical efficacy, its budget impact remains unknown, and the long‐term cost‐utility within the reimbursement context needs further estimates.
Xichen Tong, Yawen Zhang, Lei Zhang, Luying Zhang   +3 more
wiley   +1 more source

Comparing patient and healthcare professional preferences for patient-centered integrated care in China: a best-worst scaling study

BMC Health Services Research
Background Since 2016, China has implemented integrated care reforms to address service fragmentation. However, there is limited evidence regarding the preferences of key stakeholders for the various dimensions of integrated care.
Yue Yin, Wenqing Gao, Xiujuan Cui, Minlin Li, Zijin Fang, Yixin Du, Wenxi Tang   +6 more
doaj   +1 more source

Comparative Cardiovascular Risk of Abatacept and Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis With and Without Diabetes Mellitus: A Multidatabase Cohort Study

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2018
BackgroundWe examined the cardiovascular risk of abatacept compared with tumor necrosis factor (TNF) inhibitors in patients with rheumatoid arthritis with and without diabetes mellitus (DM). Methods and ResultsWe conducted a cohort study of patients with
Eun Ha Kang, Yinzhu Jin, Gregory Brill, Jennifer Lewey, Elisabetta Patorno, Rishi J. Desai, Seoyoung C. Kim   +6 more
doaj   +1 more source

Motives and predictors of modified Atkins diet discontinuation as treatment of adults with drug‐resistant epilepsy

Epilepsia, EarlyView.
Abstract Objective This study was undertaken to explore the motives and predictors of modified Atkins diet (MAD) discontinuation as a treatment of adults with drug‐resistant epilepsy (DRE). Methods A single‐center observational longitudinal study was made of a cohort of patients treated with MAD during the first 6 years at a multidisciplinary ...
Raquel Samões, Ana Cavalheiro, Maria Manuel Tavares, Catarina Teixeira, Bárbara Leal, João Chaves, Sara Cavaco   +6 more
wiley   +1 more source

Perceptions of AI-based tools among polish medical university students

BMC Medical Education
Background In the face of rapid technological progress and the growing presence of artificial intelligence (AI) in everyday life, it is increasingly important to examine how these tools can support or transform the way future healthcare professionals ...
Piotr Ratajczak, Oliwia Słowik, Julia Cynar, Dorota Kopciuch, Anna Paczkowska, Tomasz Zaprutko, Krzysztof Kus   +6 more
doaj   +1 more source

Differences in drug use between men and women: an Italian cross sectional study

BMC Women's Health, 2017
Background Drugs are the most important treatment option for most diseases, and the majority of medical consultations result in a prescription. Women and men receive different drug prescriptions and differ in therapeutic response to pharmacological ...
Daria Putignano, Dario Bruzzese, Valentina Orlando, Denise Fiorentino, Alessia Tettamanti, Enrica Menditto   +5 more
doaj   +1 more source

Enhancing Medication Adherence in Older Adults: A Systematic Review of Evidence‐Based Strategies

Journal of the American Geriatrics Society, EarlyView.
Designing and implementing an intervention aimed at improving adherence in older subjects. ABSTRACT Background Medication adherence is essential for achieving favorable health outcomes, particularly in older adults with multiple chronic conditions.
Stefano Scotti, Luca Pasina, Carlotta Lunghi, Emanuel Raschi, Andrea Rossi, Elena Olmastroni, Marco Salluzzo, Sara Mucherino, Valentina Orlando, Alessandro Nobili, Enrica Menditto, Elisabetta Poluzzi, Manuela Casula   +12 more
wiley   +1 more source

Review of the pharmacoeconomics of early treatment of multiple sclerosis using interferon beta

Neuropsychiatric Disease and Treatment, 2013
Florian Castrop, Bernhard Haslinger, Bernhard Hemmer, Dorothea Buck Department of Neurology, Technische Universität München, Munich, Germany Abstract: Multiple sclerosis (MS) is a common neurological disease with increasing incidence and ...
Castrop F, Haslinger B, Hemmer B, Buck D
doaj  

Pharmacoeconomics of Antibiotic Therapy

Canadian Journal of Infectious Diseases, 1994
During the past few years new drugs with greatly improved efficacy have become available to physicians and their patients. The higher purchase price of these new drugs is quite important and is quoted as a significant cause of the escalating cost of ...
Jacques Le Lorier
doaj   +1 more source